2008-07-02 19:39:17 -
www.companiesandmarkets.com adds new report - GenVec Inc - Premium Company Profile www.companiesandmarkets.com/Summary-Company-Profile/GenVec-Inc-P ..
Introduction
GenVec is a clinical-stage biopharmaceutical company utilizes its proprietary platform, adenovector technology. It´s collaborations with National Institute of Health, US Navy and US Department of Agriculture to use its delivery platform to develop vaccines against HIV, influenza, malaria, and foot and mouth disease have established it as potential player in Vaccine market.
Scope
Contains corporate strategy, value chain
presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
GenVec is a clinical-stage biopharmaceutical company that specializes in using adenovector-based vectors to deliver gene-based therapies for the treatment of various cancers, including pancreatic, head and neck, and rectal cancer.The company´s lead candidate, TNFerade, is in Phase II/III clinical trial for the treatment of pancreatic cancer.
The key elements of the company´s business strategy include: advancing the clinical development of its product candidate, TNFerade; continue application of its proprietary adenovector technology to develop new products and strengthening the company´s financial and market position through its funded vaccine programs.
The company´s total revenues increased at a CAGR of 22.5% during 2002-2006, from $8.4 million to $18.9 million. This represents an absolute total growth of +$10.5 million for total revenues. The company´s only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.
Reasons to Purchase
Access all the important information and analysis on the company in a single report
Understand company´s strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company´s adjusted five year financial data along with key ratios and market capitalization
